COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025
Press release on total voting rights and shares of the Company as of April 30, 2025 under Article 223-16 of the General Regulations of the Autorité des Marchés Financiers -
-
-
-
COMMUNIQUÉ DE PRESSE
Vision Marine Technologies Files Patent for Advanced Software-Based Overload Protection in Electric Marine Powertrains
Vision Marine Technologies files U.S. patent application for software-driven overload protection in E-Motion™ HV powertrain, enhancing safety and efficiency for electric boats -
-
COMMUNIQUÉ DE PRESSE
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
ABIONYX Pharma communique le nombre de droits de vote et d'actions en circulation, conformément aux exigences de l'AMF. La société se consacre au développement de biomédicaments novateurs pour les maladies inflammatoires les plus sévères -
COMMUNIQUÉ DE PRESSE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Monthly statement of total voting rights and shares for ABIONYX Pharma on Euronext Paris, including total gross and net voting rights as of April 30, 2025 -
